0.31. CMF vs tamoxifen (TAM) plus goserelin (GOS) as adjuvant treatment of ER positive (+VE) preperimenopausal breast cancer patients (pts). Preliminary results of an ongoing Italian breast cancer adjuvant study group (GROCTA) trial

✍ Scribed by F. Boccardo; A. Rubagotti; D. Amoroso; M. Mesiti; O. Geraci; P. Delia; E. Villa; D. Aldrighetti; F. Genta; P. Sismondi; L. Irtelli; D. Donati; P. Paccini; A. Farris; G. Schieppati

• Book ID: 114317037
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 155 KB
• Volume: 6
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(97)90612-3